ALB and pancreatic adenocarcinoma: Regarding the classification success for these cut-off points, in patients with pancreatic adenocarcinoma, the sensitivity for the HALP score was 89.3% with a specificity of 55.6%, and the sensitivity for the LCR question was 79.8% with a specificity of 64.3%, while the sensitivity for the albumin value was 88.6% and the specificity was 78.8%.